Pfizer CEO Says They Found More Than 50 Fake Drugs Just Last Year

In light of the  fake Avastin scandal, many are now wondering exactly how many counterfeit medications are on the market today.  According to an interview with The Financial Times, one CEO says that the problem is much more wide spread than one would think.

Pfizer CEO Ian Read said the company confirmed more than 50 fakes of its drugs in at least 101 countries just last year.

An investigation by The Wall Street Journal reported that in 2010, fake Avastin was found in Shanghai and in Syria a year earlier. The issue has again prompted discussions of whether unique labeling or other procedures are needed to protect against counterfeits, which can be useless and deadly. Counterfeits have been more of a problem in developing countries that have less stringent oversight. But with the money that can be made, there are fears more fakes will start showing up in places like the U.S. and Europe.

Bill Donnelly, Pfizer’s chief of anti-counterfeiting for North America said that

“Outlaw pill makers usually want to make sure they work well enough to keep users coming back but take risks with health.”

“They are more likely to put too much active ingredient,” said Donnelly, a retired FBI agent. “If it works too well, people will buy it again.”  And that is the risk, he said.

“The problem is you don’t know how these things are manufactured,” he said. “They are potentially putting their lives in danger because they really don’t know where these things are coming from.”

Pfizer, which works internationally with law-enforcement to uncover as well as prosecute cases of counterfeiting, said it has tested seized pills that contained wallboard or been colored by the same paint used on highways.

“Another thing with counterfeits is they are often manufactured in places where you wouldn’t even want to walk around,” Donnelly said. “Some of these places are filthy.”

About 8.3 million fake Pfizer tablets were seized worldwide in 2010, according to the company, and 57 percent of those were copies of Viagra.

No comments yet.

Leave a Reply

  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Merck’s Falsification of Vaccine Data Exposed

Merk’s dirty little secret has been exposed. A pair of lawsuits, one filed by former employees of Merck and the other by doctors, alleged the company knew its mumps vaccine was less effective than the supposed 95 percent efficiency level. According to court documents the former virologists employed by Merck filed a whistleblower lawsuit four […]

Testosterone Therapy Linked To Heart-Attack, Stroke and Death

Millions of men have turned to testosterone therapy to treat symptoms of aging. However, they may not be aware that they are putting themselves at risk for heart attack or stroke. According to the latest study published in the journal PLOS ONE, researchers report that within 90 days of taking the hormone the risk of […]

What Is Doribax?

According to the FDA the antibacterial drug Doribax, that has been used to treat patients who develop pneumonia on ventilators, carries an increased risk of death and has a lower clinical cure rate by injection compared a similar drug known as Primaxin. What is Doribax? Doribax is an antibiotic that fights serious infections caused by […]

Is Using Tylenol or Ibuprofen During Pregnancy linked to ADHD?

What is a mother to do if she becomes ill during pregnancy?  The risks of consuming common drugs when pregnant are complex.  Although many doctors assure mothers that taking Tylenol is safe, a recent study by JAMA Pediatrics suggests otherwise.  The study found that mothers who used Tylenol for fever reduction while pregnant reported greater […]

Paxil Linked To Breast Cancer

City of Hope Cancer researchers indicate that a new test called the AroER Tri-Screen, desgined to look for drug side effects that could cause cancer, found a potential link between Paxil and breast cancer.  Paxil is a widely prescribed anti depressant. Research Researchers have found that Paxil has a weak estrogen effect that could increase […]

Latest Medical Device Injury News

Report Raises Concerns Over Heart Defibrillator Leads

The Food and Drug Administration (FDA) has just announced that they received a report that a St. Jude Durata cardiac defibrillator lead conductor became externalized; meaning the wire carrying electricity from the heart defibrillator to the heart was exposed through its insulation, a potentially dangerous and life-threatening defect.

HeartSine Class 1 Defibrillator Recall

HeartSine sent out a letter to customers in September, warning that the defibrillators may intermittently turn on and off, eventually depleting the battery.

FDA Medical Device Approval Based On Little Evidence

More than half of the high-risk cardiovascular devices approved in the past decade had no supporting active control data.

St. Jude Medical Gets FDA Warning

St. Jude Medical Inc. said it received a FDA warning about manufacturing and quality-control problems at its Sylmar, California, plant.

Hospira Still Facing Manufacturing And Regulatory Issues

Hospira has sent out 11 device notifications so far in 2013, including recall and device corrections. The company also said it sent notices to customers about some of its infusion pumps that had to either be recalled, fixed or adjusted.